the staff of the Ridgewood blog
Ridgewood NJ, Valley Health System is providing leading-edge therapy to patients at high-risk with mild to moderate COVID-19 infection and within 10 days of symptom onset. The treatment involves a single infusion of monoclonal antibodies, which are laboratory-made proteins that mimic the immune system’s ability to fight off harmful antigens, such as viruses.
Continue reading Valley Hospital Offering Leading-Edge Antibody Therapy for COVID-19
